使用警語:中文譯文來源為 Google 翻譯,僅供參考,實際內容請以英文原文為主
Operator
Ladies and gentlemen, thank you for standing by. Welcome to the Stepan Company first quarter 2008 earnings conference call. During the presentation all participants will be in listen-only mode. Afterwards we'll conduct a question-and-answer session. (OPERATOR INSTRUCTIONS) As a reminder this conference is being recorded Wednesday, April 23, 2008. It is now my pleasure to turn the conference over to Mr. Jim Hurlbutt, Vice President and Chief Financial Officer.
- VP, CFO
Good afternoon and thank you for joining us. Before I begin please note that information in this conference call contains forward-looking statements which are not historical facts. These statements involve risks and uncertainties that could cause actual results to differ materially, including but not limited to prospects for our foreign operations, global and regional economic conditions, and other factors detailed in the Company's Securities and Exchange Commission filings.
As I report to you today on Stepan's first quarter 2000 results, I am pleased to say that Stepan has started off 2008 on a very strong footing. Our ability to successfully execute op our strategy across our global operations during the first quarter resulted in significant improvement in our earnings. Sales grew in each of our three core business segments. Surfactants, polymers, and specialty products. One of the key factors in this performance has been our ability to fairly pass along the impact of rapidly rising raw material prices to our customers during the quarter.
Overall, our ongoing focus on improved profitability was clear as our year-over-year net income and earnings per share growth rates significantly outpaced our growth in net sales. At this point let me turn now to our first quarter 2008 operating results, starting with the top line, total net sales for the first quarter were $381 million, an increase of 22% from the $313 million in sales reported for the same period in 2007. Net sales benefited from higher selling prices, accounting for 20 percentage points net sales growth and the positive effect of foreign currency translation which accounted for 4 percentage points of net sales growth. This was partially offset by lower sales volume which reduced net sales by 2 percentage points.
The recent surge in crude oil has led to further increases in our raw material costs as of April 1, and we have implemented further price increases to recover these costs. Net income for the first quarter increased 54% to $8.7 million, or $0.85 per diluted share, compared to net income of $5.7 million or $0.56 per diluted share in the year-ago quarter. First quarter gross profit increased by $11 million, up 32% year-over-year, supported by a significant improvement in surfactant earnings. Gross margin jumped roughly 90 basis points to 12% of revenue from a gross margin of 11.1% in the year-ago period.
Operating income increased $6.3 million in the first quarter, or 60%, due to the $11 million improvement in gross profit, partially offset by a $4.7 million increase in operating expenses. Regarding Stepan's foreign exchange impact for the quarter, the net effect of favorable translation gains and foreign exchange losses was pretax income of $800,000 as compared to 0 impact in the year-ago period.
Turning to operating expenses, first quarter operating expenses totaled $29 million, up 19% as compared to the same period last year. A significant factor in this increase was the rise in deferred compensation expense which increased $2 million from income of $1.3 million in the year-ago period to expense this quarter of $700,000. As you will recall, the accounting requirement for the Company's fully funded deferred compensation plan results in an expense being recognized when the price of Stepan Company stock or mutual funds held in the plan rise and income being recognized when they decline. Aside from the previously discussed impact of deferred compensation on operating expenses, the remaining increases in marking, admin, and research and development were largely attributable to a $1.5 million in higher wage and benefit costs associated with higher long-term incentive plan costs as well as bonus and profit sharing provisions.
Let's move now to a review of the performance of our three business segments. First, we'll look at surfactants. The largest segment of our business which accounts for 76% of net sales for the quarter. Net sales of surfactants were up 23% year over year on a 3% decline in volume as compared to the year-ago period. Surfactant gross profit increased by $11.4 million or 51% to $33.5 million in the quarter driven by improved product and customer mix as well as continuing efforts to recover higher raw material costs and selling prices, particularly for fabric softeners. Sales of higher value added surfactants and agricultural products and the broader distributor market also contributed to the improved customer and product mix. Increased fabric softener capacity in Mexico has also eliminated prior year outsourcing costs, further benefiting the gross margin.
The gross profit improvement was broad-based geographically with North America contributing the largest portion of the improvement but Latin America and Europe also contributed significantly. The marginal decline in surfactant volume was due to lower volumes sold into the personal care market due in large part to a large customer switching from a low active to a high active formulation that results in lower sales volume for Stepan. This was partially offset by improved commodity, laundry, and fabric softener volumes. Sales of biodiesel produced a slight operating profit compared to a year ago loss on similar sales volumes. Biodiesel's profit margins continue to be depressed due to the high soybean oil prices.
Moving now to our polymer segment which represented 21% of revenue in the first quarter, net sales of polymers rose 18% year-over-year to $80.8 million. Polymer segment gross profit declined by $900,000, or 8%, and a 21% year-over-year decline in phthalic anhydride volume, which was due to the recessionary environment in the automotive, recreational vehicle, and boating industries where PA is used in resins for plastic and composite materials. Offsetting this decline has been a rise in Stepan's internal consumption of phthalic anhydride in our polyol product which continues to experience significant growth. Internal consumption of phthalic anhydride now represents more than a third of capacity.
Polyol gross profit improved on a 20% increase in volume. Our polyol product is primarily used in rigid foam insulation for commercial roofing. As we have stated in the past, the majority of this market is for replacement roofs versus new construction, which based on current market conditions is an important distinction. The replacement market has not yet experienced recessionary effects due in part to the energy saving characteristics associated with increased insulation usage. European polyol sales volume has grown significantly. Polyol sales volume in China remains lower than anticipated but China does project to be profitable for the full year 2008.
Finally, our specialty product segment accounted for around 3% of the Company's sales in the first quarter. Net sales of specialty products were up 31% year-over-year to $10.3 million. Specialty products first quarter gross profit increased by $100,000, or 6% year-over-year, driven by improved volume and margins in the food ingredients market.
Looking at other income and expenses, interest expense rose 2% due to higher average debt levels brought about by increased working capital requirements. The first quarter loss associated with our 50% equity stake in the Philippine joint venture totaled $300,000, up from a loss of $100,000 in the year-ago period. While a combination of planned and unplanned production interruptions were a primary factor in the higher loss from this facility, we believe improving volume and pricing in the region are projected to lead to a slight profit for the full-year period.
Moving on to the other net expense line, which totaled roughly $1.5 million for the quarter, compared to just $18,000 in the year-ago period, the increase is largely attributable to a $1.3 million loss on mutual fund investments held for our deferred compensation plan. In January of 2008, the Company adopted new accounting rules, statement of financial standard number 159, the fair value option for financial assets and financial liabilities, which allows for the marking to market of financial instruments such as these in the income statement which were previously recorded in accumulated other comprehensive income in the stockholders equity section of the balance sheet. The tax rate for the quarter was 31.8%, compared to 29.6% in the year-ago period.
Turning to the balance sheet, consolidated debt as of March 31, 2008, was $156.9 million, up from $128 million at the end of 2007 and $148.9 million at the end of the year-ago quarter. Our total debt to total capitalization at quarter end was 41.7% compared to 38.3% in the fourth quarter of 2007. Capital expenditures were $10.6 million in the first quarter, down 8% from the same quarter last year. This is mainly due to project timing on a full-year basis we expect our 2008 full-year capital expenditures to be in the range of 40 million to $45 million.
Looking at our cash flows during the quarter, working capital requirements increased by $41.6 million compared to a $15 million increase in the same quarter of 2007. This was due to higher receivables driven by increased sales and higher inventory levels.
Our outlook going forward, overall we are quite pleased with our progress in the first quarter. While we remain vigilant of the signs of weakness in the economy and the potential impact of a recession on our target markets and customers, based on the global composition of our customer base and the defensive characteristics of many of our business segments, we believe our first quarter improvement is sustainable and anticipate continued profit growth over 2007. This concludes my prepared remarks. At this time I would like to turn the call over for questions. Operator, please review the instructions for the question portion of today's call.
Operator
Thank you. (OPERATOR INSTRUCTIONS) And our first question comes from the line of [Aaron Weakman] with Appaloosa.
- Analyst
I was wondering how much sulfur, sulfuric acid and phosphoric acid do you consume? Are those some of the products that you're most worried about? And do you still have the brunt of the multiple 100% price increases in those products to be realized?
- VP, CFO
Well, we're -- our primary -- in the sulfur segment, we primarily use sulfur trioxide, so at some of our plants we buy raw sulfur and burn it to create sulfur trioxide. In one plant, our largest, we buy sulfur trioxide. While those prices are starting to run up because of the runup in sulfur, the brunt of our costs -- and that's a very small percentage of our finished product, because that's actually what we use as the feedstock to cause the reaction in our primary feedstocks. The larger volume items that are causing us a runup in costs are (inaudible) benzine which is the base feedstock for most of our surfactant product, as well as alcohol, both natural and synthetic. Those have run up in tandem with crude oil, not quite always in symmetry, but that's where the biggest portion of our raw material increase in the surfactant side has come from. On the polymer side, we've add rapid run-up in ortho-Xylene which is a crude oil derivative s well as die ethylene glycol which has moderated slightly recently but it's been very volatile for the last two years.
- Analyst
Okay. And then you guys don't consume a lot of phosphoric acid?
- VP, CFO
To my knowledge, none.
- Analyst
Was there seasonality in this quarter sulfactants?
- VP, CFO
Well, we tend to slow down a little bit in the fourth quarter, then come out fairly strong in the first. But usually the first, second, and third can all be fairly strong quarters. There's to reason to suspect that the first quarter volume, since actually the volume wasn't all that strong, we're down overall 3%, so no, we're not seeing any concerns that the volume issue in the first quarter will be any different going forward. We hope that some of the opportunities we have at hand will kick in, in the next couple of quarters. So barring a significant recession, which, again, would primarily be on some of the functional product sides where we sell into paints or building product applications. But on the cleaning compound side, we're not expecting a significant downturn.
- Analyst
Okay. And one last question. Will your price increases, or the bulk of them, have they been put forward for April or did you have some of them beginning in March? Looks like your competitors had March 1.
- VP, CFO
Well, wee've gone with traditionally quarterly increases where we can -- if a January 1, price increase didn't stick right away on January 1, it might have gotten dragged into February and March, but I think the majority of our recent price increases were targeting April 1, but we have had price increases virtually every quarter for the last two years. So this is just a continuation in trying to make sure we're staying current with the volatile raw material environment we're in.
- Analyst
Okay. Thank you.
- VP, CFO
Thank you.
Operator
(OPERATOR INSTRUCTIONS) Our next question comes from the line of Beverly Machtinger with Grace and White. Please proceed.
- Analyst
Hi, Jim.
- VP, CFO
Hello, Beverly.
- Analyst
I was wondering if you could just update a little bit about what's happening in China, especially since you sort of alluded that it might actually contribute a little something by year end?
- VP, CFO
Yes. As I said in the past, the progress in China has been much slower than we first anticipated. We had hoped to be profitable much sooner than this point in time, but we do believe it will be profitable this year. Most of that capacity was built to serve the Chinese market. We are actually, because we have capacity, utilizing some of that to supplement our global requirements, because we are out of capacity now in -- at our German plant, serving primarily the European and Middle Eastern market. So we have tapped the Chinese plant to help supplement some of the European and Middle Eastern requirements. We are also shipping polyol from the U.S. to Europe. So I guess it's fortunate we have that capacity, but we'd like to be selling it in the Chinese market and building a larger position and market share in the Chinese market.
Conversions have been slow. Getting the engineers at the -- at our customers to operate their equipment to handle our feedstock has been a little more challenging than we anticipated. They have to convert their production line and there's always some resistance to change, but given the -- what we believe long term are the improved performance characteristics, fire retardancy, and cost factors, we still believe the Chinese market will be a very big market. Europe converted to our product fairly slowly as well. It really was only in the last two or three years that we finally saw significant market conversion. We're still optimistic about China. We're just, obviously forced to be a little more patient than we originally had planned.
- Analyst
And then on the biodiesel, situation, I was wondering what created the turnaround there in profitability, and is that something where it will at least stay profitable versus being a drain?
- VP, CFO
That one is very difficult to forecast, because crude oil has been so volatile. Nobody quite anticipated soybean oil and the other natural oils following crude as fast as they did. It didn't take very long before those shot up and took the margin out of biodiesel. But then now you've got crude going up, even more dramatic rate, which has kind of opened up the spread between crude and so I bane, allow ago small margin. So is that margin sustainable, boy, I wish I knew for sure. We believe with some blending of talo, as the feedstock we're using talo and soybean oil on a blended basis to get our cost down, so we continue to participate in this market profitably. And at the same time, we want to make sure that we find alternative uses for that equipment, which we've done. We've actually ran other products on that equipment when we have other opportunities that are more profitable. So we're trying to balance what may happen and have contingencies for utilizing those assets for more profitable business.
- Analyst
Okay, great. Thanks, Jim.
Operator
And there would appear to be no further questions at this time.
- VP, CFO
Okay. Well, I would just like to thank everybody for participating in today's call. Thank you very much.
Operator
And, ladies and gentlemen, that does conclude the conference call for today. We thank you for your participation and ask that you please disconnect your lines.